u/marit_laurent
Contributes reviews on supplier material. Based in Brno.
member · joined 14 May 2025
Comments — page 3 of 5
comment on packaging: what the trials say vs what this community says in c/coldchain · 60 points · 3 months ago
Germany to Germany: 24 days with ERP and 23 days with QSC. Same route, different carriers, variance is real.
comment on small win: stability stopped being a problem at week 85 in c/coldchain · 29 points · 3 months ago
lyophilised powder is far more forgiving than reconstituted solution
comment on switched from 5mg to 2.5mg and the reflux got better, not worse in c/dosinglogs · 5 points · 3 months ago
logs that stop 11 days get Concluded flair automatically
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on [Results] 62 weeks, 45kg, and FLOW was the hard part in c/trialwatch · 1 points · 4 months ago
press release STEP posts must be flaired until a publication exists
comment on 21 months in and excursion is still the thing I get wrong in c/coldchain · 1 points · 4 months ago
customs clearance often breaks the cold chain, factor that in
comment on the packaging thing finally clicked for me and I want to write it down in c/coldchain · 7 points · 4 months ago
no tracking numbers, no full addresses, no label photos — instant removal
comment on [Vendor] WXT order #4 — Germany, 13 days, no drama, receipts inside in c/retatrutide · 1 points · 5 months ago
the weight curves are unusually steep, which makes predicting individual response harder
comment on stalled for 18 weeks at 7.5mg and I refuse to panic this time in c/orforglipron · 6 points · 5 months ago
the supply conversation changes if this approves
comment on week 16 check-in — 42kg down, constipation manageable, one thing confusing me in c/retatrutide · 61 points · 5 months ago
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
comment on someone explain lost money to me like I have not read a paper in years in c/darkspot · 1 points · 5 months ago
decisions people would not make again
comment on small win: SURMOUNT stopped being a problem at week 65 in c/trialwatch · 131 points · 5 months ago
Disagree. What you are describing is consistent with endpoint, not with what you concluded.
comment on [Question] the UK — has anyone got a straight answer on ATTAIN in c/orforglipron · 13 points · 5 months ago
Australia here. Waited 18 months on a list, gave up, went private, and the total cost was roughly what I expected.
comment on why does nobody talk about shortage list in c/compounding · 12 points · 5 months ago
Strongly agree. API source transparency matters.
comment on below spec — 5 things I got wrong before I got it right in c/darkspot · 69 points · 5 months ago
I am going to push back on this slightly.
comment on unpopular opinion: telehealth is massively overrated in c/compounding · 2 points · 5 months ago
state board rules differ, say which state
comment on [Lab] 16th independent test on QSC, and the trend is the interesting part in c/retatrutide · 374 points · 6 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on the hazard ratio thing finally clicked for me and I want to write it down in c/trialwatch · 139 points · 6 months ago
dropout handling matters, especially on GI-heavy populations
comment on [Discussion] can we stop arguing about lyophilised until somebody posts a number in c/coldchain · 2 points · 6 months ago
This is correct. Dry powder is way more robust than liquid.
comment on [Discussion] reimbursement is doing more work than we give it credit for in c/glp1eu · 60 points · 6 months ago
Yeah, EU rules is usually national rules.
comment on [Question] 503B — what am I missing here in c/compounding · 4 points · 7 months ago
telehealth costs shortage list plus compounding markup, total varies